Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
29 May 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-asks-stealth-biotherapeutics-resubmit-application-rare-genetic-condition-2025-05-29/
30 Apr 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-delays-decision-stealth-biotherapeutics-rare-genetic-disorder-drug-2025-04-29/
24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-to-present-new-bevemipretide-data-at-arvo-annual-meeting-302436558.html
21 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/stealth-biotech-bags-rights-velavigo-bispecific-440m-deal
11 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-positive-vote-from-fda-advisory-committee-meeting-supporting-potential-approval-of-elamipretide-for-the-treatment-of-barth-syndrome-302273995.html
10 Oct 2024
// ENDPTS
https://endpts.com/fda-again-raises-doubts-on-stealths-ultra-rare-disease-drug-ahead-of-adcomm/
ABOUT THIS PAGE